SCOPOLAMINE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for scopolamine and what is the scope of freedom to operate?

Scopolamine is the generic ingredient in two branded drugs marketed by Actavis Labs Ut Inc, Mylan Technologies, Padagis Us, Rhodes Pharms, Riconpharma Llc, Zydus Pharms, and Baxter Hlthcare Corp, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for scopolamine. Ten suppliers are listed for this compound.

Sponsor	Phase
Yale University	Phase 1
Janssen Scientific Affairs, LLC	Phase 1
Dartmouth-Hitchcock Medical Center	Phase 1

Sponsor

Phase

Yale University

Phase 1

Janssen Scientific Affairs, LLC

Phase 1

Dartmouth-Hitchcock Medical Center

Phase 1

US Patents and Regulatory Information for SCOPOLAMINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Technologies	SCOPOLAMINE	scopolamine	SYSTEM;TRANSDERMAL	203753-001	Jun 19, 2019	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Zydus Pharms	SCOPOLAMINE	scopolamine	SYSTEM;TRANSDERMAL	217893-001	Aug 29, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Baxter Hlthcare Corp	TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Padagis Us	SCOPOLAMINE	scopolamine	SYSTEM;TRANSDERMAL	078830-001	Jan 30, 2015	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Actavis Labs Ut Inc	SCOPOLAMINE	scopolamine	SYSTEM;TRANSDERMAL	208769-001	Jan 10, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare Corp	TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Baxter Hlthcare Corp	TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Baxter Hlthcare Corp	TRANSDERM SCOP	scopolamine	SYSTEM;TRANSDERMAL	017874-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

SYSTEM;TRANSDERMAL

Approved Prior to Jan 1, 1982

⤷ Sign Up

SYSTEM;TRANSDERMAL

Approved Prior to Jan 1, 1982

⤷ Sign Up

SYSTEM;TRANSDERMAL

Approved Prior to Jan 1, 1982

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	2
Applicants:	7
NDAs:	7
Drug Master File Entries:	21
Finished Product Suppliers / Packagers:	10
Raw Ingredient (Bulk) Api Vendors:	41
Clinical Trials:	80
Patent Applications:	6,653
Drug Prices:	Drug price trends for SCOPOLAMINE
What excipients (inactive ingredients) are in SCOPOLAMINE?	SCOPOLAMINE excipients list
DailyMed Link:	SCOPOLAMINE at DailyMed

Drug Class	Anticholinergic
Mechanism of Action	Cholinergic Antagonists

SCOPOLAMINE - Generic Drug Details

What are the generic sources for scopolamine and what is the scope of freedom to operate?

Summary for SCOPOLAMINE

Recent Clinical Trials for SCOPOLAMINE

Pharmacology for SCOPOLAMINE

Anatomical Therapeutic Chemical (ATC) Classes for SCOPOLAMINE

US Patents and Regulatory Information for SCOPOLAMINE

Expired US Patents for SCOPOLAMINE

Make Better Decisions: Try a trial or see plans & pricing